deferoxamine and vlx600

deferoxamine has been researched along with vlx600 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, P; Bremberg, U; D'Arcy, P; Fryknäs, M; Gullbo, J; Larsson, R; Linder, S; Nygren, P; Olofsson, MH; Persson, I; Schughart, LK; Senkowski, W; Zhang, X1

Other Studies

1 other study(ies) available for deferoxamine and vlx600

ArticleYear
Iron chelators target both proliferating and quiescent cancer cells.
    Scientific reports, 2016, 12-07, Volume: 6

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Inhibitory Concentration 50; Iron Chelating Agents; MCF-7 Cells; Mitochondria; Ribonucleotide Reductases; Structure-Activity Relationship; Triazoles

2016